# FDA Inspection 1009423 - Numare Spectralab, Inc. - May 02, 2017

Source: https://www.keypedia.com/records/fda_inspections/numare-spectralab-inc/58c5e080-4aef-49f1-b04d-05c2ab4fceb9
Source feed: FDA_Inspections

> FDA Inspection 1009423 for Numare Spectralab, Inc. on May 02, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1009423
- Company Name: Numare Spectralab, Inc.
- Inspection Date: 2017-05-02
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1009423 - 2017-05-02](https://www.keypedia.com/records/fda_inspections/numare-spectralab-inc/6b949c0d-6463-4c99-83fb-af5cf82254d3)
- [FDA Inspection 592681 - 2009-06-26](https://www.keypedia.com/records/fda_inspections/numare-spectralab-inc/9fa72435-5eda-4410-a24b-60b153b1ba93)

Company: https://www.keypedia.com/companies/numare-spectralab-inc/63e3135b-dcc9-49bb-827d-07e5c2145f22

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c